Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
复制标题
DOI：
10.18632/aging.103000
复制
发表时间：
2020-04-15
期刊：
影响因子：
5.2
通讯作者：
Huang, Yan
中科院分区：
文献类型：
--
作者：
Wang, Bolin;Li, Ruobao;Huang, Yan
目前，冠状病毒病2019(新冠肺炎)患者数量迅速增加，但共病与新冠肺炎患者之间的关系仍不明确。其目的是探索常见合并症的存在是否会增加新冠肺炎患者的风险。使用电子平台(PubMed、Cochrane图书馆、Embase和其他数据库)进行文献检索，以获取截至2020年3月1日发表的相关研究报告。每项研究的研究终点的相关数据被提取并合并。所有数据用Stata12.0软件进行统计分析。最终，6个研究中的1,558名新冠肺炎患者进入Meta分析。高血压(OR：2.29，P
Currently, the number of patients with coronavirus disease 2019 (COVID-19) has increased rapidly, but relationship between comorbidity and patients with COVID-19 still not clear. The aim was to explore whether the presence of common comorbidities increases COVID-19 patients' risk. A literature search was performed using the electronic platforms (PubMed, Cochrane Library, Embase, and other databases) to obtain relevant research studies published up to March 1, 2020. Relevant data of research endpoints in each study were extracted and merged. All data analysis was performed using Stata12.0 software. A total of 1558 patients with COVID-19 in 6 studies were enrolled in our meta-analysis eventually. Hypertension (OR: 2.29, P